Cargando…
Effect of Semaglutide versus placebo on psychotic symptoms and quality of life - a pre-specified secondary analysis of HISTORI: A randomized clinical trial in people with pre-diabetes and schizophrenia
INTRODUCTION: Life expectancy of people with schizophrenia is reduced by 10-20 years compared to the general population. The excess mortality is part due to an increased prevalence of cardiovascular disease, prediabetes and obesity, which are in part due to antipsychotic treatment. Gaining weight is...
Autores principales: | Uhrenholt, N., Ganeshalingam, A., Arnfred, S., Frystyk, J., Gæde, P., Bilenberg, N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9567870/ http://dx.doi.org/10.1192/j.eurpsy.2022.2064 |
Ejemplares similares
-
Symptom Profiles in Psychotic Disorder Not Otherwise Specified
por: Widing, Line, et al.
Publicado: (2020) -
Placebo-controlled randomised trial with liraglutide on magnetic resonance endpoints in individuals with type 2 diabetes: a pre-specified secondary study on ectopic fat accumulation
por: Bizino, Maurice B., et al.
Publicado: (2019) -
Speech-on-speech masking and psychotic symptoms in schizophrenia
por: Wu, Chao, et al.
Publicado: (2018) -
Arcuate Fasciculus Abnormalities and Their Relationship with Psychotic Symptoms in Schizophrenia
por: Abdul-Rahman, Muhammad Farid, et al.
Publicado: (2012) -
Schizophrenia-Like Psychotic Symptoms Associated to Leigh Syndrome
por: Jaballah, F., et al.
Publicado: (2023)